Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver

This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 1983-04, Vol.51 (7), p.1254-1260
Hauptverfasser: Miyazaki, Masaru, Makowka, Leonard, Falk, Rudolf E., Falk, William, Venturi, David, Ambus, Ulo, Falk, Judith A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1260
container_issue 7
container_start_page 1254
container_title Cancer
container_volume 51
creator Miyazaki, Masaru
Makowka, Leonard
Falk, Rudolf E.
Falk, William
Venturi, David
Ambus, Ulo
Falk, Judith A.
description This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.
doi_str_mv 10.1002/1097-0142(19830401)51:7<1254::AID-CNCR2820510714>3.0.CO;2-0
format Article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmed_primary_6825049</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR2820510714</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2164-fe76be3e56cb6b970b4b4e0b2d62ddb72bb7fd3695510e38e70f462a4bb545fb3</originalsourceid><addsrcrecordid>eNpVkN1Kw0AQhRdRaq0-grCXepE6-59UEUrUtlAsiIJ3S7bZpStJE5K00rc3obXQqzPDOTNwPoRiAkMCQB8IRCoAwukdiUIGHMi9ICP1RKjgo9F49hLE7_EHDSkIAorwZzaEYbx4pAGcof7x-hz1ASAMBGffl-iqrn_aVVHBeqgnQyqAR300me5KWzUrW-XFcmXzohuT0m4av8R-jbd-W2BfF1nS2BS3UbepfbHGhcNtEldJgzO_tdU1unBJVtubgw7Q19vrZzwN5ovJLB7Pg5ISyQNnlTSWWSGXRppIgeGGWzA0lTRNjaLGKJcyGYm2mmWhVeC4pAk3RnDhDBug2_3fcmNym-qy8nlS7fShUOu7vf_rM7s72gR0h1Z3cHQHR_-j1YJopTu0uiWrT8lqpkHHC007OXHYH03Zc-I</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</creator><creatorcontrib>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</creatorcontrib><description>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19830401)51:7&lt;1254::AID-CNCR2820510714&gt;3.0.CO;2-0</identifier><identifier>PMID: 6825049</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Alanine Transaminase - blood ; Alkaline Phosphatase - blood ; Animals ; Aspartate Aminotransferases - blood ; Bilirubin - blood ; Chemotherapy, Cancer, Regional Perfusion - adverse effects ; Chemotherapy, Cancer, Regional Perfusion - methods ; DNA - biosynthesis ; Fluorouracil - administration &amp; dosage ; Fluorouracil - toxicity ; Hot Temperature - therapeutic use ; Liver - drug effects ; Liver - pathology ; Male ; Rats ; Sodium Chloride - adverse effects ; Time Factors</subject><ispartof>Cancer, 1983-04, Vol.51 (7), p.1254-1260</ispartof><rights>Copyright © 1983 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6825049$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miyazaki, Masaru</creatorcontrib><creatorcontrib>Makowka, Leonard</creatorcontrib><creatorcontrib>Falk, Rudolf E.</creatorcontrib><creatorcontrib>Falk, William</creatorcontrib><creatorcontrib>Venturi, David</creatorcontrib><creatorcontrib>Ambus, Ulo</creatorcontrib><creatorcontrib>Falk, Judith A.</creatorcontrib><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><title>Cancer</title><addtitle>Cancer</addtitle><description>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</description><subject>Alanine Transaminase - blood</subject><subject>Alkaline Phosphatase - blood</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Bilirubin - blood</subject><subject>Chemotherapy, Cancer, Regional Perfusion - adverse effects</subject><subject>Chemotherapy, Cancer, Regional Perfusion - methods</subject><subject>DNA - biosynthesis</subject><subject>Fluorouracil - administration &amp; dosage</subject><subject>Fluorouracil - toxicity</subject><subject>Hot Temperature - therapeutic use</subject><subject>Liver - drug effects</subject><subject>Liver - pathology</subject><subject>Male</subject><subject>Rats</subject><subject>Sodium Chloride - adverse effects</subject><subject>Time Factors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1983</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkN1Kw0AQhRdRaq0-grCXepE6-59UEUrUtlAsiIJ3S7bZpStJE5K00rc3obXQqzPDOTNwPoRiAkMCQB8IRCoAwukdiUIGHMi9ICP1RKjgo9F49hLE7_EHDSkIAorwZzaEYbx4pAGcof7x-hz1ASAMBGffl-iqrn_aVVHBeqgnQyqAR300me5KWzUrW-XFcmXzohuT0m4av8R-jbd-W2BfF1nS2BS3UbepfbHGhcNtEldJgzO_tdU1unBJVtubgw7Q19vrZzwN5ovJLB7Pg5ISyQNnlTSWWSGXRppIgeGGWzA0lTRNjaLGKJcyGYm2mmWhVeC4pAk3RnDhDBug2_3fcmNym-qy8nlS7fShUOu7vf_rM7s72gR0h1Z3cHQHR_-j1YJopTu0uiWrT8lqpkHHC007OXHYH03Zc-I</recordid><startdate>19830401</startdate><enddate>19830401</enddate><creator>Miyazaki, Masaru</creator><creator>Makowka, Leonard</creator><creator>Falk, Rudolf E.</creator><creator>Falk, William</creator><creator>Venturi, David</creator><creator>Ambus, Ulo</creator><creator>Falk, Judith A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19830401</creationdate><title>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</title><author>Miyazaki, Masaru ; Makowka, Leonard ; Falk, Rudolf E. ; Falk, William ; Venturi, David ; Ambus, Ulo ; Falk, Judith A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2164-fe76be3e56cb6b970b4b4e0b2d62ddb72bb7fd3695510e38e70f462a4bb545fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1983</creationdate><topic>Alanine Transaminase - blood</topic><topic>Alkaline Phosphatase - blood</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Bilirubin - blood</topic><topic>Chemotherapy, Cancer, Regional Perfusion - adverse effects</topic><topic>Chemotherapy, Cancer, Regional Perfusion - methods</topic><topic>DNA - biosynthesis</topic><topic>Fluorouracil - administration &amp; dosage</topic><topic>Fluorouracil - toxicity</topic><topic>Hot Temperature - therapeutic use</topic><topic>Liver - drug effects</topic><topic>Liver - pathology</topic><topic>Male</topic><topic>Rats</topic><topic>Sodium Chloride - adverse effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miyazaki, Masaru</creatorcontrib><creatorcontrib>Makowka, Leonard</creatorcontrib><creatorcontrib>Falk, Rudolf E.</creatorcontrib><creatorcontrib>Falk, William</creatorcontrib><creatorcontrib>Venturi, David</creatorcontrib><creatorcontrib>Ambus, Ulo</creatorcontrib><creatorcontrib>Falk, Judith A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miyazaki, Masaru</au><au>Makowka, Leonard</au><au>Falk, Rudolf E.</au><au>Falk, William</au><au>Venturi, David</au><au>Ambus, Ulo</au><au>Falk, Judith A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1983-04-01</date><risdate>1983</risdate><volume>51</volume><issue>7</issue><spage>1254</spage><epage>1260</epage><pages>1254-1260</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>This report describes a system of in vivo isolated perfusion of the rat liver. The effects of perfusion with 5‐fluorouracil (5‐FU) (0.125–1.5 g/kg) on survival, liver function, and hepatic regeneration are studied. A dose of 0.125–0.25 g/kg of 5‐FU produced acceptable toxicity with 0% and 25% mortality rate, but induced liver dysfunction indicated by abnormal biochemical values and severe inhibition of hepatic regeneration. Doses of 0.5 g/kg, 1.0 g/kg, and 1.5 g/kg produced a mortality of 60%, 100%, and 100%, respectively. Regional hyperthermia (37–43°C) achieved by perfusion of the liver with heated saline produced an adverse effect on survival, liver function and hepatic regeneration, which are both temperature‐ and perfusion time‐dependent. Hyperthermochemotherapy using in vivo isolated hepatic perfusion might be acceptable for the treatment of unresectable liver cancer, but should not be utilized as an adjuvant therapy prior to hepatic resection without the use of hepatic growth factors which could reverse the inhibitory effect of hepatic perfusion.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>6825049</pmid><doi>10.1002/1097-0142(19830401)51:7&lt;1254::AID-CNCR2820510714&gt;3.0.CO;2-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1983-04, Vol.51 (7), p.1254-1260
issn 0008-543X
1097-0142
language eng
recordid cdi_pubmed_primary_6825049
source MEDLINE; Alma/SFX Local Collection
subjects Alanine Transaminase - blood
Alkaline Phosphatase - blood
Animals
Aspartate Aminotransferases - blood
Bilirubin - blood
Chemotherapy, Cancer, Regional Perfusion - adverse effects
Chemotherapy, Cancer, Regional Perfusion - methods
DNA - biosynthesis
Fluorouracil - administration & dosage
Fluorouracil - toxicity
Hot Temperature - therapeutic use
Liver - drug effects
Liver - pathology
Male
Rats
Sodium Chloride - adverse effects
Time Factors
title Hyperthermochemotherapeutic in vivo isolated perfusion of the rat liver
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T18%3A11%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperthermochemotherapeutic%20in%20vivo%20isolated%20perfusion%20of%20the%20rat%20liver&rft.jtitle=Cancer&rft.au=Miyazaki,%20Masaru&rft.date=1983-04-01&rft.volume=51&rft.issue=7&rft.spage=1254&rft.epage=1260&rft.pages=1254-1260&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19830401)51:7%3C1254::AID-CNCR2820510714%3E3.0.CO;2-0&rft_dat=%3Cwiley_pubme%3ECNCR2820510714%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/6825049&rfr_iscdi=true